Aehr Test Systems (NASDAQ:AEHR) Director Rhea Posedel Sells 8,413 Shares

Aehr Test Systems (NASDAQ:AEHR) Director Rhea Posedel sold 8,413 shares of the business’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $130.00, for a total transaction of $1,093,690.00. Following the sale, the director owned 387,962 shares in the company, valued at approximately $50,435,060. This trade represents a 2.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Aehr Test Systems Price Performance

NASDAQ:AEHR opened at $123.30 on Friday. The firm’s 50-day moving average price is $92.12 and its 200-day moving average price is $71.00. The company has a market capitalization of $4.02 billion, a PE ratio of -513.73 and a beta of 3.10. Aehr Test Systems has a 1-year low of $16.38 and a 1-year high of $133.35.

Institutional Investors Weigh In On Aehr Test Systems

Large investors have recently bought and sold shares of the business. Royal Bank of Canada lifted its stake in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after acquiring an additional 36,364 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after purchasing an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after purchasing an additional 1,145 shares during the last quarter. Legal & General Group Plc lifted its position in Aehr Test Systems by 110.8% during the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after purchasing an additional 3,617 shares during the period. Finally, Rhumbline Advisers lifted its position in Aehr Test Systems by 3.1% during the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after purchasing an additional 1,254 shares during the period. 69.69% of the stock is currently owned by institutional investors.

Key Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat order supports demand for Aehr’s FOX systems and reinforces its opportunity in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent operating updates showed record quarterly bookings of $60.7 million, an approximately $100.6 million backlog and fiscal 2027 revenue guidance of $130 million to $150 million. These metrics improve revenue visibility and suggest accelerating adoption of wafer-level burn-in for complex AI chips. Can Aehr’s $22 Million AI Order Unlock a Bigger WLBI Opportunity?
• Neutral Sentiment: Management will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide additional details on customer demand, backlog conversion and the 2027 outlook, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares on August 12, including CEO Gayn Erickson, COO Adil Engineer and directors Laura Oliphant and Rhea J. Posedel. The reported transactions totaled approximately 65,130 shares and $8.5 million, potentially signaling profit-taking and adding selling pressure after the stock’s rapid appreciation. Aehr CEO Stock Sale Filing
• Negative Sentiment: Analyst commentary cautioned that AEHR’s valuation has become demanding after its substantial gains. With a negative price-to-earnings ratio and high expectations already reflected in the shares, any slowdown in orders, execution or AI spending could trigger further profit-taking.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on AEHR. Jefferies Financial Group initiated coverage on shares of Aehr Test Systems in a research note on Thursday. They set a “buy” rating and a $175.00 target price for the company. Lake Street Capital restated a “buy” rating and issued a $110.00 price target on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Wall Street Zen raised Aehr Test Systems from a “sell” rating to a “hold” rating in a research report on Saturday, July 18th. Craig Hallum reiterated a “buy” rating and set a $125.00 price objective on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Finally, Zacks Research raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, Aehr Test Systems has a consensus rating of “Buy” and a consensus target price of $136.67.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.